2023-06-05 08:49:46 ET
-
Personalised hormone therapy provider, biote ( NASDAQ: BTMD ) prices an underwritten offering of 5,217,392 shares at a price of $5.35 per share.
-
Underwriters have a 30-day option to purchase an aggregate of not more than 782,608 additional shares.
-
The company will not receive any of the proceeds from the sale of the shares offered by the selling stockholder.
-
The offering is expected to close on or about June 7, 2023.
-
The stock price is down 6.9% during pre-market hours.
For further details see:
Biote down 7% on pricing secondary offering